pyrazinamide has been researched along with Essential Polyarteritis in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imanishi, H | 1 |
| Tsuruta, D | 1 |
| Oshimo, T | 1 |
| Sowa, J | 1 |
| Mizuno, N | 1 |
| Nakagawa, K | 1 |
| Ishii, M | 1 |
1 other study available for pyrazinamide and Essential Polyarteritis
| Article | Year |
|---|---|
Cutaneous polyarteritis nodosa induced by Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung; Male; Middle | 2012 |